Ph.D., CEO, PrecisionLife
Biography
Steve is a serial technology entrepreneur with over 25 years’ experience developing and commercializing ground-breaking data science and informatics in the healthcare, life sciences and agri-food sectors. Never afraid to innovate, Steve has an established track record in building world-class companies, teams and products working at senior levels in the UK, EU and US for Fortune 500 and start-up companies. He is a former Global Director of Research Informatics for Astra A/B and has consulted with drug discovery and safety teams in over 20 biopharma companies.
AI & Data Science Showcase:
PrecisionLife
PrecisionLife is changing the way the world looks at predicting, preventing, and treating chronic diseases. Our unique AI and combinatorial analysis platforms generate more insights from patient data than anyone else on the planet to understand disease biology better and stratify patients at unprecedented resolution.
Precision Medicine in Chronic Diseases: Better Outcomes, Faster
Analysis of large patient datasets using unique combinatorial analytics is enabling the stratification of complex diseases into distinct patient subgroups that have different causes and influences. This offers huge promise for innovation in drug discovery and the delivery of personalized care to patients.
Session Abstract – PMWC 2022 Silicon Valley
Track 7 - June 28 10.00 A.M.-1.15 P.M.,Track 7 - June 29 11.00 A.M.-1.15 P.M.,Track 7 - June 30 9.00 A.M.-11.15 A.M.
The PMWC 2022 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
